Clay-based hemostatic agents and devices for the delivery thereof
View Patent ↗A hemostatic device for promoting the clotting of blood includes a gauze substrate, a clay material disposed on the gauze substrate, and also a polyol such as glycerol or the like disposed on the gauze substrate to bind the clay material. When the device is used to treat a bleeding wound, at least a portion of the clay material comes into contact with blood emanating from the wound to cause the clotting. A bandage that can be applied to a bleeding wound to promote the clotting of blood includes a flexible substrate and a gauze substrate mounted thereon. The gauze substrate includes a clay material and a polyol. A hemostatic sponge also includes a gauze substrate and a dispersion of hemostatic material and a polyol on a first surface of the substrate.
1. A hemostatic device for promoting the clotting of blood comprising:
an absorbent substrate;
a clay material applied to the absorbent substrate, the clay material comprising kaolin, and the absorbent substrate existing separately from the clay material before the clay material is applied to the absorbent substrate;
a glycerol applied to the absorbent substrate; and
an alginate applied to the absorbent substrate;
wherein the hemostatic device is subjected to a drying process.
2. The hemostatic device of claim 1 , wherein the clay material, the glycerol, and the alginate are applied to the absorbent substrate at the same time.
3. The hemostatic device of claim 1 , wherein the device is configured such that when exposed to blood from a portion of a human body, the clay material to comes into direct contact with the blood to assist in accelerating clotting.
4. The hemostatic device of claim 1 , wherein the absorbent substrate comprises a plurality of strands.
5. The hemostatic device of claim 4 , wherein interstices are formed between at least some of the plurality of strands.
6. The hemostatic device of claim 4 , wherein the plurality of strands forms a gauze.
7. The hemostatic device of claim 6 , wherein the clay material is positioned so as to be exposed on at least two sides of the gauze substrate.
8. The hemostatic device of claim 1 , wherein the absorbent substrate is flexible to allow the device to conform closely to a shape of the bleeding wound and to retain the shape of the bleeding wound.
9. The hemostatic device of claim 1 , wherein the clay material further comprises attapulgite, bentonite, or combinations of the foregoing materials.
10. The hemostatic device of claim 1 , wherein at least one of the glycerol and the alginate is applied to the substrate by a spraying process.
11. The hemostatic device of claim 1 , wherein the clay material and at least one of the glycerol and the alginate are applied to the substrate by a spraying process.
12. The hemostatic device of claim 1 , wherein at least one of the glycerol and the alginate is applied to the substrate by immersing the substrate in a liquid comprising the glycerol and/or the alginate.
13. The hemostatic device of claim 4 , wherein the gauze substrate comprises woven strands.
14. The hemostatic device of claim 1 , wherein the clay material and at least one of the glycerol and the alginate are applied to the substrate by a slot-die technique.
15. The hemostatic device of claim 1 , wherein the clay material and at least one of the glycerol and the alginate are applied to the strands by a slot-die technique.
16. A hemostatic device for promoting the clotting of blood comprising:
a plurality of strands;
a hemostatic material applied to the plurality of strands, the strands being formed before the hemostatic material is applied to the plurality of strands;
glycerol and an alginate applied to the plurality of strands;
wherein the hemostatic device is subjected to a drying process after the hemostatic material is applied to the plurality of strands;
wherein the device is capable of absorbing blood; and
wherein the device is configured such that when applied to a bleeding wound, application of the device is capable of causing blood to contact at least a portion of the plurality of strands, causing at least a portion of the hemostatic material to come into contact with the blood to assist in accelerating clotting.
17. The hemostatic device of claim 16 , wherein the plurality of strands are configured to include interstices between at least some of the plurality of strands.
18. The hemostatic device of claim 16 , wherein the plurality of strands are incorporated into a woven or non-woven material.
19. The hemostatic device of claim 16 , wherein the plurality of strands is flexible to allow the device to form to a shape of the bleeding wound and to retain a shape of the bleeding wound.
20. The hemostatic device of claim 16 , wherein the alginate comprises calcium alginate.
21. The hemostatic device of claim 16 , wherein the hemostatic material comprises kaolin particles having diameters of less than about 0.2 mm.